Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum  M.C. Peral,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
Clinical Microbiology and Infection
Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter 
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
C-reactive protein as a marker of infection in critically ill patients
Herpes zoster in non-hospitalized children
Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis  C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Dynamics of serum procalcitonin in patients after major neurosurgery
B. Beović, S. Kreft, J. Osredkar, D. Keše, B. Bonač-Tuma 
R. Cantón  Clinical Microbiology and Infection 
Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations  R. Ashley-Morrow,
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic  A.S.
Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement 
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan  P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho 
Bacteriophages as a reservoir of extended-spectrum β -lactamase and fluoroquinolone resistance genes in the environment  E. Marti, E. Variatza, J.L. Balcázar 
Results from a mathematical model for human monocytic ehrlichiosis
Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients  K. Bochennek, L. Tramsen, N. Schedler,
Vector control: a cornerstone in the malaria elimination campaign
A. Oliver, A. Mena  Clinical Microbiology and Infection 
T-cell responses against tuberculin and sensitin in children with tuberculosis and non- tuberculosis mycobacterial lymphadenopathy  K. Magdorf, S.D. Schuck,
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates  G.A. Tramper-Stranders,
High serum neopterin and low cytokine values may indicate a non-bacterial etiology for fever of unknown origin in neutropenic patients  Per Engervall,
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
The practice of travel medicine in Europe
Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography  J. Elias, C. Schoen, G. Heinze,
Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during.
Update on antifungal resistance in Aspergillus and Candida
Abstracts cont. Clinical Microbiology and Infection
Abstracts cont. Clinical Microbiology and Infection
N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch 
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
Fibronectin concentrations in catheter sepsis
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of source of infection and vancomycin AUC0–24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus.
Three years experience of real-time PCR for the diagnosis of Q fever
Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study) 
Impact of antibiotic restrictions: the patient's perspective
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum  M.C. Peral, M.M. Rachid, N.M. Gobbato, M.A. Huaman Martinez, J.C. Valdez  Clinical Microbiology and Infection  Volume 16, Issue 3, Pages 281-286 (March 2010) DOI: 10.1111/j.1469-0691.2009.02793.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 (a) Ulcer area size and time of treatment in diabetic (filled line) and non-diabetic (dotted line) patients. Each point represents the mean ± SD wound area (diabetics n = 14; non-diabetics n = 20). (b) Each symbol represents the percentage of wound reduction area in each individual patient on day 30 after the start of the treatment. Open squares, diabetics (D); filled squares, non-diabetics (ND). Clinical Microbiology and Infection 2010 16, 281-286DOI: (10.1111/j.1469-0691.2009.02793.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Percentage of interleukin (IL)-8-positive cells from the ulcer bed from non-diabetics (filled squares) and diabetics (open squares) with ulcers as a function of time. Boxes refer to the 25th (bottom) and 75th (top) percentiles, and the median is the horizontal line inside; fences refer to maximum and minimum values and open circles represent outliers. *Significantly lower compared to days 5 and 10 (p <0.001) within the same group. **Significantly higher compared to day 10 (p <0.05) within the same group. Clinical Microbiology and Infection 2010 16, 281-286DOI: (10.1111/j.1469-0691.2009.02793.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Percentage of positive peripheral blood polymorphonuclear neutrophils (PBPMN) for interleukin (IL)-8 production from different groups of individuals: normal (N), diabetics without ulcers (D), non-diabetics with ulcers (NDU), diabetics with ulcers (DU). The assay was carried out with PBPMN under basal conditions (open squares) and with PBPMN infected with Pseudomonas aeruginosa preincubated either with (dark grey squares) or without Lactobacillus plantarum (light grey squares). Boxes refer to the 25th (bottom) and 75th (top) percentiles, and the median is the horizontal line inside; fences refer to maximum and minimum values and open circles represent outliers. Significantly lower than the other basal values: #p <0.001. Significantly higher than the basal values within the same group: *p <0.001; **p <0.01. Significantly lower than P. aeruginosa infected alone within the same group: §p <0.001. Clinical Microbiology and Infection 2010 16, 281-286DOI: (10.1111/j.1469-0691.2009.02793.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions